US 11,896,742 B2
Compositions and devices incorporating water-insoluble therapeutic agents and methods of the use thereof
John Jackson, West Vancouver (CA); Lindsay Stuart Machan, West Vancouver (CA); and Kevin Letchford, Vancouver (CA)
Assigned to COOK MEDICAL TECHNOLOGIES LLC, Bloomington, IN (US)
Filed by Cook Medical Technologies LLC, Bloomington, IN (US)
Filed on Jun. 28, 2021, as Appl. No. 17/360,329.
Application 17/360,329 is a continuation of application No. 16/408,663, filed on May 10, 2019, granted, now 11,058,805.
Application 16/408,663 is a continuation of application No. 16/001,514, filed on Jun. 6, 2018, granted, now 10,328,183, issued on Jun. 25, 2019.
Application 16/001,514 is a continuation of application No. 15/386,662, filed on Dec. 21, 2016, granted, now 10,016,536, issued on Jul. 10, 2018.
Application 15/386,662 is a continuation of application No. 14/880,332, filed on Oct. 12, 2015, granted, now 9,572,914, issued on Feb. 21, 2017.
Application 14/880,332 is a continuation of application No. 14/454,325, filed on Aug. 7, 2014, granted, now 9,180,226, issued on Nov. 10, 2015.
Prior Publication US 2021/0386918 A1, Dec. 16, 2021
This patent is subject to a terminal disclaimer.
Int. Cl. A61L 31/16 (2006.01); A61K 31/337 (2006.01); A61L 27/34 (2006.01); A61L 27/44 (2006.01); A61L 27/54 (2006.01); A61L 29/16 (2006.01); A61L 31/10 (2006.01); A61K 31/353 (2006.01); A61K 31/436 (2006.01); A61L 29/08 (2006.01); A61L 31/08 (2006.01); A61K 31/58 (2006.01); A61M 25/09 (2006.01); A61M 25/10 (2013.01)
CPC A61L 31/16 (2013.01) [A61K 31/337 (2013.01); A61K 31/353 (2013.01); A61K 31/436 (2013.01); A61K 31/58 (2013.01); A61L 27/34 (2013.01); A61L 27/44 (2013.01); A61L 27/54 (2013.01); A61L 29/08 (2013.01); A61L 29/085 (2013.01); A61L 29/16 (2013.01); A61L 31/08 (2013.01); A61L 31/10 (2013.01); A61M 25/09 (2013.01); A61M 25/10 (2013.01); A61L 2300/416 (2013.01); A61L 2300/426 (2013.01); A61L 2300/602 (2013.01); A61L 2300/606 (2013.01); A61L 2300/61 (2013.01); A61L 2420/06 (2013.01); A61M 2025/105 (2013.01); H05K 999/99 (2013.01)] 20 Claims
 
1. A composition comprising:
a therapeutic preparation comprising a gallate containing compound and a water-insoluble therapeutic agent at least partly dissolved in a solid phase of the gallate containing compound, where the gallate containing compound is present in an amount by weight equal to or greater than the amount by weight of the water-insoluble therapeutic agent.